Interactions in vivo between the Vif Protein of HIV-1 and the precursor (Pr55GAG) of the virion nucleocapsid proteins

Archives of Virology

Volumn 154, Issue 11, 2009, Pages 1797-1805

  Syed, Farhatullah ^a   McCrae, Malcolm A ^a  

^a UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE; P55 GAG PRECURSOR PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1; PROTEIN PRECURSOR; VIF PROTEIN; VIF PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1;

ANIMAL; ARTICLE; CELL STRAIN COS1; CERCOPITHECUS; GENE DELETION; GENE EXPRESSION REGULATION; HUMAN IMMUNODEFICIENCY VIRUS 1; METABOLISM; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE; VIRION;

ANIMALS; CERCOPITHECUS AETHIOPS; COS CELLS; GENE DELETION; GENE EXPRESSION REGULATION, VIRAL; GLUTATHIONE; HIV-1; PROTEIN PRECURSORS; PROTEIN STRUCTURE, TERTIARY; VIF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; VIRION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MAMMALIA;

EID: 70350646903     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-009-0520-8     Document Type: Article

References (41)

1. Adekale MA, Cane PA, McCrae MA (2005) Changes in the Vif protein of HIV-1 associated with the development of resistance to inhibitors of viral protease. J Med Virol 75:195-201.
2. Arya SK, Guo C, Josephs SF, Wong-Staal F (1985) Trans-activator gene of human T-lymphotropic virus type III (HTLV-III). Science 229:69-73.
3. Baraz L, Hutoran M, Blumenzweig I, Katzenellenbogen M, Friedler A, Gilon C, Steinitz M, Kotler M (2002) Human immunodeficiency virus type 1 Vif binds the viral protease by interaction with its N-terminal region. J Gen Virol 83:2225-2230.
4. Borman AM, Quillent C, Charneau P, Dauguet C, Clavel F (1995) Human immunodeficiency virus type 1 Vif- mutant particles from restrictive cells: role of Vif in correct particle assembly and infectivity. J Virol 69:2058-2067.
5. Bouyac M, Courcoul M, Bertoia G, Baudat Y, Gabuzda D, Blanc D, Chazal N, Boulanger P, Sire J, Vigne R, Spire B (1997) Human immunodeficiency virus type 1 Vif protein binds to the Pr55Gag precursor. J Virol 71:9358-9365.
6. Bouyac M, Rey F, Nascimbeni M, Courcoul M, Sire J, Blanc D, Clavel F, Vigne R, Spire B (1997) Phenotypically Vif-human immunodeficiency virus type 1 is produced by chronically infected restrictive cells. J Virol 71:2473-2477.
7. Boyce M, Willingmann P, McCrae M (1999) Identification of a functionally important amino acid residue near to the amino-terminus of the human immunodeficiency virus type 1 Vif protein. Virus Genes 19:15-22.
8. Cen S, Guo F, Niu M, Saadatmand J, Deflassieux J, Kleiman L (2004) The interaction between HIV-1 Gag and APOBEC3G. J Biol Chem 279:33177-33184.
9. Conticello SG, Harris RS, Neuberger MS (2003) The Vif protein of HIV triggers degradation of the human antiretroviral DNA deaminase APOBEC3G. Curr Biol 13:2009-2013.
10. Desrosiers RC (1992) HIV with multiple gene deletions as a live attenuated vaccine for AIDS. AIDS Res Hum Retroviruses 8:411-421.
11. Erickson-Viitanen S, Manfredi J, Viitanen P, Tribe DE, Tritch R, Hutchison CA 3rd, Loeb DD, Swanstrom R (1989) Cleavage of HIV-1 gag polyprotein synthesized in vitro: sequential cleavage by the viral protease. AIDS Res Hum Retroviruses 5:577-591.
12. Fan L, Peden K (1992) Cell-free transmission of Vif mutants of HIV-1. Virology 190:19-29.
13. Fouchier RA, Simon JH, Jaffe AB, Malim MH (1996) Human immunodeficiency virus type 1 Vif does not influence expression or virion incorporation of gag-, pol-, and env-encoded proteins. J Virol 70:8263-8269.
14. + T lymphocytes. J Virol 66:6489-6495.
15. Gabuzda DH, Li H, Lawrence K, Vasir BS, Crawford K, Langhoff E (1994) Essential role of vif in establishing productive HIV-1 infection in peripheral blood T lymphocytes and monocyte/macrophages. J Acquir Immune Defic Syndr 7:908-915.
16. Gluzman Y (1981) SV40-transformed simian cells support the replication of early SV40 mutants. Cell 23:175-182.
17. Harmache A, Russo P, Guiguen F, Vitu C, Vignoni M, Bouyac M, Hieblot C, Pepin M, Vigne R, Suzan M (1996) Requirement of caprine arthritis encephalitis virus vif gene for in vivo replication. Virology 224:246-255.
18. Harris RS, Bishop KN, Sheehy AM, Craig HM, Petersen-Mahrt SK, Watt IN, Neuberger MS, Malim MH (2003) DNA deamination mediates innate immunity to retroviral infection. Cell 113:803-809.
19. Hoglund S, Ohagen A, Lawrence K, Gabuzda D (1994) Role of vif during packing of the core of HIV-1. Virology 201:349-355.
20. Imai Y, Nakamura M (1988) The importance of threonine-301 from cytochromes P-450 (laurate (omega-1)-hydroxylase and testosterone 16 alpha-hydroxylase) in substrate binding as demonstrated by site-directed mutagenesis. FEBS Lett 234:313-315.
21. Lee TH, Coligan JE, Allan JS, McLane MF, Groopman JE, Essex M (1986) A new HTLV-III/LAV protein encoded by a gene found in cytopathic retroviruses. Science 231:1546-1549.
22. Liu B, Yu X, Luo K, Yu Y, Yu XF (2004) Influence of primate lentiviral Vif and proteasome inhibitors on human immunodeficiency virus type 1 virion packaging of APOBEC3G. J Virol 78:2072-2081.
23. Liu B, Sarkis PT, Luo K, Yu Y, Yu XF (2005) Regulation of Apobec3F and human immunodeficiency virus type 1 Vif by Vif-Cul5-ElonB/C E3 ubiquitin ligase. J Virol 79:9579-9587.
24. Luo K, Liu B, Xiao Z, Yu Y, Yu X, Gorelick R, Yu XF (2004) Amino-terminal region of the human immunodeficiency virus type 1 nucleocapsid is required for human APOBEC3G packaging. J Virol 78:11841-11852.
25. Madani N, Kabat D (1998) An endogenous inhibitor of human immunodeficiency virus in human lymphocytes is overcome by the viral Vif protein. J Virol 72:10251-10255.
26. Mangeat B, Turelli P, Caron G, Friedli M, Perrin L, Trono D (2003) Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 424:99-103.
27. Marin M, Rose KM, Kozak SL, Kabat D (2003) HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation. Nat Med 9:1398-1403.
28. Mehle A, Goncalves J, Santa-Marta M, McPike M, Gabuzda D (2004) Phosphorylation of a novel SOCS-box regulates assembly of the HIV-1 Vif-Cul5 complex that promotes APOBEC3G degradation. Genes Dev 18:2861-2866.
29. Oberste MS, Gonda MA (1992) Conservation of amino-acid sequence motifs in lentivirus Vif proteins. Virus Genes 6:95-102.
30. Ochman H, Gerber AS, Hartl DL (1988) Genetic applications of an inverse polymerase chain reaction. Genetics 120:621-623.
31. Sadowski I, Bell B, Broad P, Hollis M (1992) GAL4 fusion vectors for expression in yeast or mammalian cells. Gene 118:137-141.
32. Sheehy AM, Gaddis NC, Choi JD, Malim MH (2002) Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418:646-650.
33. Sheehy AM, Gaddis NC, Malim MH (2003) The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif. Nat Med 9:1404-1407.
34. Simon JH, Gaddis NC, Fouchier RA, Malim MH (1998) Evidence for a newly discovered cellular anti-HIV-1 phenotype. Nat Med 4:1397-1400.
35. Stopak K, de Noronha C, Yonemoto W, Greene WC (2003) HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability. Mol Cell 12:591-601.
36. Tian C, Yu X, Zhang W, Wang T, Xu R, Yu XF (2006) Differential requirement for conserved tryptophans in human immunodeficiency virus type 1 Vif for the selective suppression of APOBEC3G and APOBEC3F. J Virol 80:3112-3115.
37. Vasavada HA, Ganguly S, Germino FJ, Wang ZX, Weissman SM (1991) A contingent replication assay for the detection of protein-protein interactions in animal cells. Proc Natl Acad Sci USA 88:10686-10690.
38. Yu X, Yu Y, Liu B, Luo K, Kong W, Mao P, Yu XF (2003) Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex. Science 302:1056-1060.
39. Yu Y, Xiao Z, Ehrlich ES, Yu X, Yu XF (2004) Selective assembly of HIV-1 Vif-Cul5-ElonginB-ElonginC E3 ubiquitin ligase complex through a novel SOCS box and upstream cysteines. Genes Dev 18:2867-2872.
40. Zhang H, Yang B, Pomerantz RJ, Zhang C, Arunachalam SC, Gao L (2003) The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA. Nature 424:94-98.
41. Zheng YH, Irwin D, Kurosu T, Tokunaga K, Sata T, Peterlin BM (2004) Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication. J Virol 78:6073-6076.